Localization of mRNAs is one of many aspects of cellular organization that requires the cytoskeleton. In Drosophila, microtubules are known to be required for correct localization of developmentally important mRNAs and proteins during oogenesis; however, the role of the actin cytoskeleton in localization is less clear. Furthermore, it is not known whether either of these cytoskeletal systems are necessary for maintenance of RNA localization in the early embryo. We have examined the contribution of the actin and microtubule cytoskeletons to maintenance of RNA and protein localization in the early Drosophila embryo. We have found that while microtubules are not necessary, the actin cytoskeleton is needed for stable association of nanos, oskar, germ cell-less and cyclin B mRNAs and Oskar and Vasa proteins at the posterior pole in the early embryo. In contrast, bicoid RNA, which is located at the anterior pole, does not require either cytoskeletal system to remain at the anterior. q
Introduction
The correct distribution of subcellular components is critical for proper cellular function. One mechanism for ensuring restricted distribution of particular proteins is RNA localization. In some cells it is hypothesized that localized protein synthesis resulting from RNA localization is important for simply concentrating proteins in regions of the cell where they are in high demand. In cultured ®broblasts actin RNA is targeted to the cell cortex where rapid actin assembly/disassembly occurs; in contrast, vimentin RNA and protein are found near the nucleus (Lawrence and Singer, 1986) . RNA targeting appears to be particularly important in large and/or complex cells. In neurons, for example, certain mRNAs are speci®cally localized to dendrites or the axon whereas the majority of mRNAs are found in the cell body (Davis et al., 1987; Garner et al., 1988; Litman et al., 1994; Olink-Coux and Hollenbeck, 1996) .
Perhaps the best understood cases of RNA localization are those that regulate cell fate decisions. For example, in budding yeast the decision of whether to remain the same mating-type or switch to the opposite type after cell division is controlled by the Ash1 gene (Bobola et al., 1996; Sil and Herskowitz, 1996) . The localization of Ash1 RNA to the newly formed daughter cell ensures that Ash1 protein will be concentrated in that cell and will prevent mating-type switching (Long et al., 1997; Takizawa et al., 1997) . Consequently, the mother cell switches mating-type while the daughter cell does not.
In a number of animal embryos, RNA localization is critical for proper regional expression of molecules involved in spatial patterning and cell-fate determination (reviewed in Micklem, 1995; St. Johnston, 1995) . In Xenopus, mRNAs have been identi®ed that are localized to particular regions of the oocyte (Rebagliati et al., 1985) . For example, Vg1 RNA, which encodes a TGF-b molecule, is localized to the vegetal cortex of the oocyte (Melton, 1987; Weeks and Melton, 1987) . In the C. elegans embryo, RNAcontaining P granules segregate to the posterior pole and are correlated with germ cell fate (Strome and Wood, 1982; Wolf et al., 1983) .
In Drosophila, proper RNA localization during oogenesis and maintenance during early embryonic development is necessary for the establishment of the embryonic axes. Abdominal patterning and germ cell formation rely on information localized at the posterior pole of the embryo (reviewed in St. Johnston, 1993) . Molecular genetic studies of posterior group genes, which are required for posterior patterning, have established that assembly of RNP particles in the posterior cortex is ultimately responsible for the localized production of Nanos, the posterior patterning determinant. The posterior group gene oskar is a key player in this pathway as ectopic localization of oskar RNA results in the formation of functional pole plasm at the ectopic site (Ephrussi and Lehmann, 1992) . RNA localization is also important for patterning of the anterior end of the embryo (reviewed in Driever, 1993) . bicoid RNA is localized to the anterior of the oocyte where it acts in the embryo as a localized source for a gradient of Bicoid protein that functions in a concentration-dependent manner to determine anterior-posterior polarity.
The mechanism of transport and maintenance of mRNAs in speci®c regions has been studied in several systems. During Drosophila oogenesis, microtubules (MTs) are required for transport of several mRNAs including bicoid and oskar (Pokrywka and Stephenson, 1991, 1995; Theurkauf et al., 1993; Clark et al., 1994; Glotzer et al., 1997) . In Xenopus MTs are also responsible for RNA transport (Yisraeli et al., 1990) .
The actin cytoskeleton is also involved in the asymmetric distribution of mRNAs. In Xenopus the actin cytoskeleton is required for maintenance of the vegetally localized RNA, Vg1, in the oocyte (Yisraeli et al., 1990) . Furthermore, the proper asymmetric distribution of actin RNA (Sundell and Singer, 1991) and Ash 1 RNA (Long et al., 1997; Takizawa et al., 1997) is also dependent on the actin cytoskeleton. In addition, it has been shown that P granules reach the posterior pole of the C. elegans embryo by actin-dependent cytoplasmic streaming (Strome and Wood, 1983; Hird and White, 1993) .
The role of actin in localization in Drosophila is less clear. Oocytes and embryos from females that are mutant for cytoplasmic tropomyosin, an actin binding protein, have dramatically reduced levels of oskar RNA, Vasa protein and Staufen protein at the posterior pole (Erde Âlyi et al., 1995; Tetzlaff et al., 1996) . Localization is also abnormal during oogenesis in pro®lin (chicadee) mutants (Manseau et al., 1996) . Therefore, the actin cytoskeleton in Drosophila may be necessary for transport or maintenance of localization during oogenesis. However, depolymerization of the actin cytoskeleton appears to have no effect on the initial localization of mRNAs during oogenesis (Pokrywka and Stephenson, 1991, 1995; Theurkauf et al., 1993; Clark et al., 1994; Glotzer et al., 1997) suggesting actin is not strictly required for localization during oogenesis. A requirement for the actin cytoskeleton to maintain this distribution in the embryo has not been directly tested.
We have tested whether the maintenance of localization in the early Drosophila embryo of several mRNAs (nanos, oskar, bicoid, germ cell-less and cyclin B) and proteins (Oskar and Vasa) is dependent on the actin and microtubule cytoskeletons. We have found that maintenance of the posterior localization in the early embryo of nanos, oskar, germ cell-less and cyclin B RNAs and Oskar and Vasa proteins at the posterior pole is dependent on the actin cytoskeleton but not MTs. In contrast, we found that maintenance of the anterior localization of bicoid RNA in the early embryo requires neither the actin nor the MT cytoskeleton. These results are the ®rst direct evidence for a requirement of the actin cytoskeleton in maintaining mRNA and protein localization in the early Drosophila embryo.
Materials and methods

Drug treatment of embryos
Embryos were collected for 45 min at 228C or 258C, rinsed with Triton±salt buffer (0.4% NaCl, 0.1% Triton X-100) and dechloronated with 50% bleach. After thorough washing with Triton±salt buffer, embryos were rinsed twice with 0.9% NaCl. Embryos were then treated with the desired concentration of drug in 2 ml of 0.9% NaCl and 2 ml of octane; octane permeabilizes the embryos. The drug solution was removed and the embryos were then ®xed as described below. Cytochalasin D (CD) (Sigma) was dissolved in dimethyl sulfoxide (DMSO) at 1 mg/ml. Latrunculin A (a gift of D. Schafer and J. Cooper) was dissolved in DMSO at 10 mM. Colchicine (Sigma) was dissolved in 95% ethanol at 10 mg/ml. Control embryos were incubated as described above with solvent only; the maximum concentration of DMSO or ethanol used was 1%.
Preparation of embryos for in situ hybridization
Embryos to be used for in situ hybridization with oskar, germ cell-less, bicoid and cyclin B were ®xed in 4% paraformaldehyde for 10 min according to Tautz and Pfei¯e (1989) . When hybridized with a nanos probe, embryos were ®xed in 12% formaldehyde/PEM (0.1 M pipes, pH 6.9, 1 mM EGTA and 1 mM MgCl 2 ) for 18±20 min. Embryos were stored at 2208C and then prepared for whole mount in situ hybridization (Tautz and Pfei¯e, 1989) . Embryos hybridized with germ cell-less, oskar, bicoid and cyclin B probes were stained with DAPI after in situ hybridization to determine the nuclear cycle; only unfertilized eggs and embryos at nuclear cycle 1±8 were scored. For embryos hybridized with the nanos probe, the nuclear cycle was not determined, but syncytial blastoderm embryos were excluded from the scoring.
Scoring of embryos
The amount and distribution of residual staining among embryos scored as having reduced levels of staining, particularly in drug-treated embryos, varied over a wide range. Therefore, for all probes except nanos, we quantitated drug effects by dividing the distributions into four categories. Embryos with posterior localization similar to that found in the majority of control embryos were scored as (1). Embryos with posterior localization that was weaker or more diffuse than the majority of control embryos were scored as (1/2). Embryos with greatly reduced amounts or abnormal distribution of posterior components were scored as (1/2 2). Embryos with no posterior localization were scored as (2). Embryos that fall into the (1/2) category were found at a signi®cant level in control embryos; however, embryos in the (1/2) category were found rarely in controls. We compared embryos ®xed by the standard protocol for in situ hybridization (Tautz and Pfei¯e, 1989) to those that were permeabilized and incubated as described above. There was variability in intensity of staining using even standard ®xation of embryos (i.e. without octane premeabilization), which accounts for the (1/2) control embryos. To compensate for this and for any variations in intensity in staining between experiments, in all cases, embryos treated with solvents without drugs but otherwise identically incubated, ®xed and processed for visualization of probes were prepared in parallel with drug-treated samples.
In our initial experiments, using nanos as a probe, only three categories were used to quantitate effects. In this scoring system, the (1/2) category included embryos with only slightly reduced amounts of staining, which were found at a signi®cant level in controls; in addition, it contained embryos that had a vastly altered amount or distribution of mRNA, which were found rarely in control samples, but found in large numbers in drug-treated samples.
For all treatments and probes, including those reported as data not shown,' we scored a total of at least 40 embryos in control samples. In drug-treated samples, we usually scored 90±150 embryos. All results were evaluated for signi®cance by chi-squared tests.
Preparation of embryos for antibody labeling
Embryos were ®xed in 12% formaldehyde/PEM for 10± 15 min. The vitelline membrane was removed with methanol, and embryos were then stored in methanol at 48C. Embryos were rehydrated with 1£ PBS and incubated in 1% BSA in PBST (1£ PBS/0.1% Tween 20) for 1±3 h. After overnight incubation at 48C with primary antibody in 0.1% BSA in PBST and washing with PBST, the samples were incubated for 1 h with a¯uorescently-labeled goatanti-rabbit secondary antibody conjugated to Oregon green (Molecular Probes, Inc.). Embryos then were stained with DAPI at 1 mg/ml and mounted in 90% glycerol/PBS with 1 mg/ml phenylenediamine. Immunolocalization was performed using a standard¯uorescence microscope (Nikon) or confocal imaging system (Bio-Rad 1024). Embryos were stained with anti-oskar antibody (1:5000, a gift of P. Macdonald) or anti-vasa (1:500, a gift of P. Lasko) antibody. DAPI staining allowed determination of the nuclear cycle and effectiveness of the drugs. Only unfertilized eggs and embryos at nuclear cycle 1±8 were scored.
Evaluation of the cytoskeleton in embryos treated with drugs that disrupt actin ®laments or microtubules
Drug treated and control embryos were stained with rhodamine±phalloidin (Sigma), which binds ®lamentous actin, to assess the effectiveness of CD or latrunculin A treatment. To determine the effect of colchicine treatment, drug treated and control embryos were labeled with antitubulinmonoclonal antibody (DM1A, gift of D. Kellogg and B. Alberts).
Results
Previously, we have shown that two cytoskeletal proteins, 95F unconventional myosin (an actin-binding protein) and D-CLIP-190 (a MT-binding protein), are in the same complex and are enriched at the posterior pole of the early embryo (Lantz and Miller, 1998) . We have also found that maintenance of this complex at the posterior pole is dependent on an intact actin cytoskeleton. These observations led us to ask whether the actin cytoskeleton is also required for maintenance of mRNAs and proteins involved in patterning of the early embryo.
3.1. The localization of nanos RNA in the early embryo is dependent on the actin cytoskeleton nanos RNA, which encodes the posterior patterning determinant, becomes localized to the posterior pole during late stages of oogenesis and remains at the posterior of the embryo during the ®rst few hours after fertilization (Wang et al., 1994) . We asked whether the actin and microtubule cytoskeletons are required to maintain this posterior localization in the early embryo.
Early embryos were treated with cytochalasin D (CD) to depolymerize actin ®laments or colchicine to depolymerize microtubules. When embryos were treated for 30 min with 10 mg/ml of CD, the actin cytoskeleton is completely depolymerized. Because the actin structures present in pre-blastoderm embryos are not highly organized and are dif®cult to see, we judged the effectiveness of CD treatment by rhodamine±phalloidin staining of syncytial blastoderm embryos contained in our collections for pre-blastoderm embryos. None actin structures typically seen in syncytial blastoderm embryos were observed in CD-treated embryos, while control embryos incubated with DMSO only had normal actin structures (data not shown). In CD-treated cycle 6±8 pre-blastoderm embryos, nuclei were abnormally positioned. Instead of being present in an oblate spheroid distrubution as is seen in control-incubated (Fig. 1B) and unincubated embryos, they were instead present in a sphere displaced slightly anteriorly (Fig. 1D ). The axial expansion or spreading of nuclei along the anterior-posterior axis into an oblate spheriod is an actin-dependent process (von Dassow and Schubiger, 1994) , so this distribution of nuclei is expected if actin-mediated events are disrupted. There-fore, we conclude that CD was effective in disrupting actin-based structures and processes.
When embryos were treated for 30 min with 20 mg/ml of colchicine, they lacked all normal microtubule structures such as spindles and asters; in addition, the microtubule dependent-migration of nuclei to the cortex at cycle 10 failed to occur (Zalokar and Erk, 1976) . This indicates that the microtubule cytoskeleton was severely affected under these conditions. The distribution of nanos RNA was determined by in situ hybridization in control and drug-treated embryos (Table 1) .
First, the localization of nanos RNA was examined in embryos treated for 30 min with 10 mg/ml of CD. Compared to control embryos ( Fig. 2A) , this treatment has somewhat a somewhat subtle but discernible effect on the localization of nanos RNA (Fig. 2B) . In a substantial number of embryos, the RNA was still located at the posterior pole but was more diffuse and in many embryos extended further from the posterior pole. These results led us to try a longer treatment and different concentrations of CD, since it seemed possible that a large RNA-protein complex released from the posterior pole might take a signi®cant period of time to diffuse. Longer treatments resulted in stronger effects. When embryos were treated with CD for 45 min, the amount of nanos RNA decreased at the posterior pole in the majority of embryos (Table 1, Fig. 2C±F ). These results indicate that an intact actin cytoskeleton is necessary for anchoring of nanos RNA in the posterior cortex during early embryonic development. Chi-squared tests support our conclusion that the CD effect is signi®cant (P , 0:001).
During the scoring of nanos localization, we observed that within the catagory we designated as (1/2) there was a wide variation in amount and location of RNA. In controls, the embryos that fell into this category had only slightly reduced or more diffuse nanos. However, in CD-treated embryos, there were a large number that had only very small amounts or very abnormal distributions of RNA. Thus, in addition to the quantitative differences we scored, there were qualitative differences. These differences between controls and drug-treated embryos prompted us a 1, percentage of embryos^SD with posterior localization similar to that in the majority of control embryos; 1/2, percentage of embryos^SD with posterior localization that is signi®cantly weaker or more diffuse than majority of control embryos; 2, percentage of embryos^SD with no mRNA located at the posterior pole. N is the number of embryos scored. Control includes embryos treated with solvent [DMSO (dimethylsulfoxide), ethanol (EtOH) or both] in parallel with experimental; no signi®cant difference was seen among controls.
to divide the 1/2 category into two categories (1/2 and 1/ 2 2) in subsequent experiments (see below and Section 2).
When embryos were treated with 20 mg/ml of colchicine for 45 min, there was only a slight reduction in the percentage of embryos in which the localization of nanos RNA at the posterior pole was normal (Table 1) . While this difference is signi®cant as judged by standard chi-squared tests (P , 0:002), it is small in magnitude when compared to that of CD. When embryos were treated with both CD and colchicine, the effect was similar in magnitude to CD alone (Table 1) . Thus, microtubules do not appear to be essential for maintenance of nanos RNA at the posterior pole in the early embryo.
To determine if treatment with CD causes a general disruption of embryo organization that might non-speci®-cally alter nanos RNA distribution, we performed several observations. We evaluated control and CD-treated embryos using DIC optics to determine if actin cytoskeletal disruption causes a global degeneration of the embryo. Embryos treated with (Fig. 1C) or without (Fig. 1A) drugs appeared similar in overall organization. There was a slight disruption of the uniformity of the thickness of the clear cortical cytoplasm in CD-treated embryos. This is expected since CD has been previously shown to affect the cortical cytoplasm in this manner. Nuclear distribution after CD treatment also indicates that CD-treated embryos retain many aspects of their organization. Nuclei remain approximately equally spaced and in a sphere (Fig. 1D) . Actin-dependant axial expansion of nuclei is affected by CD (as noted above). We also determined that bcd distribution is unaffected under the same conditions as those that do affect nanos (see below), strongly supporting our conclusion that the effect is speci®c.
The requirement for intact actin ®laments to maintain normal localization of nanos RNA prompted us to investigate whether the actin cytoskeleton is required for maintenance of the asymmetric distribution of other mRNAs in the early embryo. Thus, the distribution of several additional mRNAs was determined in embryos treated with CD or colchicine. Since we observed the most dramatic effect on nanos mRNA distribution with 10 mg/ml of CD for 45 min, we used this treatment for all subsequent experiments.
3.2. The anterior localization of bicoid RNA is not affected by disruption of the actin or MT cytoskeleton bicoid RNA is localized at the anterior pole during oogenesis and maintained there through early embryogenesis (reviewed in Driever, 1993) . Although the MT cytoskeleton is required for localization and maintenance of bicoid RNA during oogenesis (Pokrywka and Stephenson, 1991) , it is not known whether either the actin or the MT cytoskeleton is required for maintenance in the early embryo.
The distribution of bicoid RNA was assessed in embryos where the actin or MT cytoskeleton had been disrupted. In contrast to nanos RNA, bicoid RNA localization was not affected by either CD or colchicine (Fig. 3A,B , Table 2 ). Treated embryos were split into two pools, hybridized with an oskar or bicoid probe and processed in parallel; while oskar RNA distribution was affected (see below), the anterior localization of bicoid RNA was not affected by disruption of the actin cytoskeleton. In addition, depolymerization of both the actin and MT cytoskeletons simultaneously did not have any effect on bicoid RNA distribution. Chi-squared testing of these results indicates that the differences observed are not signi®cant (P 0:22).
Maintenance of the posterior localization in the early embryo of other mRNAs requires the actin cytoskeleton
oskar is a key gene in posterior patterning. Both oskar RNA and protein are located at the posterior pole early during oogenesis, and this localization is required for the subsequent localization of Vasa protein and other posterior mRNAs such cyclin B, germ cell-less and nanos. However, once the pole plasm components are assembled at the posterior pole, it is not known how they are anchored there or whether maintenance of the assembled complex at the posterior pole of the early embryo depends on Oskar mRNA or protein or other components. In order to determine whether the actin cytoskeleton is required to maintain posterior pole RNA localization more generally, the distribution of oskar and other mRNAs (cyclin B and germ cell-less) was examined in embryos where the actin cytoskeleton had been depolymerized.
Control, CD and colchicine treated embryos were hybridized with probes for oskar, cyclin B, or gcl. The effects of drugs on the distribution of all three RNAs were similar. We show micrographs only for oskar (Fig. 3C±F) . In most control embryos, oskar RNA is concentrated at a readily detectable level in a restricted region at the posterior pole (Fig. 3C) . In contrast, in CD-treated embryos the majority of embryos had signi®cantly less RNA at the posterior pole (Fig. 3D±F) . Often the RNA remaining at the posterior pole was present as several patches usually close to the cortex (scored as 1/2 2, Fig. 3E,F) . This pattern of staining was not observed in control embryos. Alterations in distribution of gcl and cyclin B were similar to that shown for oskar. In particular, the patchy distribution of small amounts of RNA remaining at the posterior was seen in all cases.
Quantitation of the effect of drug treatments on distribution of oskar (Table 3) , cyclin B and gcl RNA (not shown) reveals that in the majority of CD-treated embryos there is a signi®cant decrease in the level of RNA at the posterior. Depolymerization of the MT cytoskeleton did not have a signi®cant effect on any of these RNAs.
The actin cytoskeleton is required to maintain posteriorly localized proteins
We examined the cytoskeletal dependence of two posterior group proteins, Oskar (Fig. 4A±D) and Vasa (Fig. 4E±  H) . Oskar mRNA is translated at the posterior pole of the oocyte so that Oskar protein is only present there. Oskar protein is required for subsequent localization of Vasa during oogenesis. As with other posteriorly-localized components, Vasa remains localized at the posterior during early embryonic development. The distribution of both these proteins in the embryo is affected by CD but not by colchicine, like the RNAs present at the posterior. While in some CD-treated embryos the distribution of these proteins is only slightly affected (Fig. 4B,F) , the majority of embryos have little or no protein detectable at the posterior pole (Fig. 4C,D,G,H) . In many embryos, the remaining protein is in a broad rim closely apposed to the posterior membrane (Fig. 4C ). This distribution is very different from control embryos (Fig. 4A,E) where the protein is less broadly distributed and more of the protein is located internal to the cortex.
To rule out the possibility of CD effects other than disruption of the actin cytoskeleton, early embryos were also treated with latrunculin A, which depolymerizes actin by a different mechanism than CD (Cooper, 1987; Coue et al., 1987; Spector et al., 1989) . The actin cytoskeleton was completely depolymerized in embryos treated with 1 mM latrunculin A for 30 min (data not shown). Disruption of the actin cytoskeleton with latrunculin A resulted in similar effects on Oskar protein distribution when compared to cytochalasin D. The vast majority of embryos showed a signi®cant reduction in Oskar protein at the posterior pole when incubated for 30 min over a range of latrunculin A concentrations (500 nM±10 mM, Fig. 5) . In most latrunculin A-treated embryos, Oskar protein was present as a thin rim spread over a broader region of the posterior cortex similar to the CD-treated embryo shown in Fig. 4C .
Discussion
In order for cells to function properly and for global patterning and development to occur, macromolecules must be properly distributed at the subcellular level. It is clear that RNA localization is an important mechanism for cellular organization. We have shown that in the early Drosophila embryo maintenance of the proper distribution of a number of mRNAs and proteins required for posterior patterning is dependent on the actin cytoskeleton but not on microtubules. Speci®cally, the stable association of oskar, cyclin B, nanos and germ cell-less mRNAs and Oskar and Vasa proteins with the posterior of the early embryo is not properly maintained upon depolymerization of the actin cytoskeleton. In contrast, bicoid RNA which is concentrated at the anterior pole of the early embryo is not affected by disruption of either actin ®laments or microtubules. This is the ®rst demonstration that the actin cytoskeleton is necessary for RNA anchoring during early embryonic development in Drosophila.
The actin cytoskeleton is required to maintain localization of posterior components in the early embryo
All posteriorly localized mRNAs and proteins tested in this study are affected by depolymerization of the actin cytoskeleton in the early embryo. These components are thought to assemble into polar granules, a large complex containing both RNA and protein (reviewed in St. Johnston, 1993) . Oskar protein is the key component required to trigger polar granule assembly. Once this complex is assembled, it must be maintained at the posterior pole through early embryogenesis. There is no information that indicates which polar granule components are required for continued maintenance of polar granules' posterior location in the early embryo. The fact that all components we examined are affected by depolymerization of actin ®laments is consistent with the idea that the entire complex is anchored to the actin cytoskeleton. This anchoring is likely accomplished by the interaction of particular proteins in polar granules with cytoskeletal proteins. When actin is depolymerized, the complex becomes free to move. Since there are contractions and relaxations that cause cytoplasmic displacements during these divisions, even large complexes such as these may be able to move substantial distances. It is also possible that loss of actin binding disrupts the polar granules and allows dispersal of polar granule components.
The effect of actin depolymerization on the posterior pole plasm appears to be speci®c. Similar treatment does not affect bicoid mRNA localized at the anterior pole. We also evaluated overall organization of the embryo by DIC microscopy and observing the distribution of nuclei. Nuclear organization is maintained in CD-treated embryos and the distribution of large organelles and vesicles is similar in drug-treated and control embryos.
While CD had a strong effect on maintenence of posteriorly-localized components, for each gene product examined, a signi®cant number of embryos still had a small but detectable level of RNA or protein present at the posterior pole. The RNA or protein remaining for all posterior components examined is usually tightly apposed to the cortex and often patchy, in contrast to control embryos where the RNA/protein is evenly concentrated in a disclike shape at the posterior. Some components may remain because there are actin ®laments resistant to depolymerization by CD and latrunculin A. In fact, actin ®laments can still be present after CD treatment in some cells (Schliwa, 1982) . In this case, however, we do not observe any actin ®laments following these treatments and actin-dependent processes are signi®cantly affected. If there is a resistant population, it must be a minor component of the actin network which is dif®cult to visualize. Alternatively, posterior components may be anchored to another cellular component at the membrane in addition to the actin cytoskeleton, making this subset more stably associated with the cortex.
We previously showed that a complex of cytoskeletal proteins, the 95F unconventional myosin and D-CLIP-190, is enriched at the posterior of the early embryo. This complexes' posterior enrichment is also affected by treatment with CD. In those experiments, incubation for 30 min with 10 mg/ml CD caused strong effects on enrichment. In contrast, longer incubations (45 min) are required to observe similar effects on posterior group gene products. The apparent difference in sensitivity of these different components to actin disruption may be the result of differences in global distribution of the components. 95F myosin and CLIP are 78^13  12^5  6^1  3^6  97  Cyto D  8^8  27^3  59^10  5^3  166  EtOH control  72^7  20^5  2^2  6^9  65  Colchicine  65^2  22^4  12^1  1^1  78 a 1, percentage of embryos with posterior localization similar to that in the majority of control embryos; 1/ 2 , percentage of embryos with posterior localization that is weaker than majority of control embryos; 1/2 2, percentage of embryos with a signi®cant decrease or abnormal distribution of posterior mRNA; 2, percentage of embryos with no detectable mRNA located at the posterior pole. N is the number of embryos scored. Embryos were treated with 10 mg/ml of cytochalasin D for 45 min, 20 mg/ml of colchicine for 45 min, or an equal volume of DMSO or EtOH for controls. Control  79^13  19^9  7^2  2^3  145  Cyto D  75^4  18^4  2^2  4^3  72  Colchicine  82^9  16^4  2^4  0  5 7  Cyto D/colch  69  24  5  2  116 a 1, percentage of embryo^SD with anterior localization similar to that in the majority of control embryos; 1/2, percentage of embryos^SD with anterior localization that is weaker or more diffuse than majority of control embryos; 112 2, percentage of embryos^SD with a dramatic decrease or abnormal distribution of anterior mRNA; 2, percentage of embryosŜ D with no detectable mRNA located at the anterior pole. N is the number of embryos scored. Embryos were treated with 10 mg/ml of cytochalasin D for 45 min, 20 mg/ml of colchicine for 45 min, both drugs or an equal volume of DMSO or EtOH for controls. present in the entire cortex, but enriched at the posterior. Upon disruption of actin, their distribution becomes more uniform. A small amount of residual protein complex retained with polar granules at the posterior would likely be obscured by the high level of general cortical staining. In contrast, the posterior group gene products are essentially only detected in the cortex at the posterior. Therefore, the small residual amount that remains is much more visible.
The posterior maintenance of Oskar protein is affected by disruption of the actin cytoskeleton with two drugs which act in different ways to depolymerize actin ®laments. Cytochalasin D binds to and stabilizes the barbed end of the actin ®lament where rapid polymerization/depolymerization would normally occur (reviewed in Cooper, 1987) . Consequently, actin ®laments bound by CD depolymerize from the pointed end where slow polymerization/depolymeriza- (2); (E), control embryo immunolabeled with avasa antibody, scored as (1); (F), treated embryo immunolabeled with avasa antibody, scored as (1/2); (G), treated embryo immunolabeled with avasa antibody, scored as (1/2 2); (H), treated embryo immunolabeled with a vasa antibody, scored as (1/2 2). tion normally occurs. In contrast, latrunculin A depolymerizes actin ®laments by binding in a 1:1 ratio to actin monomers (Coue et al., 1987; Spector et al., 1989) . Therefore, the actin cytoskeleton is depolymerized due to turnover of existing actin ®laments and the failure to polymerize new ones. In addition, latrunculin A is reported to cause more complete and rapid depolymerization of the actin cytoskeleton. The similarity of effect of both drugs suggests that loss of localization is due to disruption of actin ®la-ments and not secondary drug effects.
The actin cytoskeleton's role during oogenesis
Previous studies have shown that depolymerization of the actin cytoskeleton with CD had no effect during oogenesis (Pokrywka and Stephenson, 1991, 1995; Theurkauf et al., 1993; Clark et al., 1994; Glotzer et al., 1997) . However, some studies provide some evidence for a role for actin during oogenesis. Pro®lin, an actin-binding protein, is required for normal RNA localization (Manseau et al., 1996) . Cytoplasmic tropomyosin, another actin binding protein, is required for localization of oskar RNA, Vasa protein and Staufen protein (Erde Âlyi et al., 1995; Tetzlaff et al., 1996) . These results raises the possibility that the actin cytoskeleton is involved in some aspect of RNA localization during oogenesis. The exact role of actin in posterior localization during oogenesis remains unclear.
4.3. The microtubule cytoskeleton is not required for pole plasm maintenance in the embryo Unlike depolymerization of actin ®laments, depolymerization of the MT cytoskeleton in the embryo had little or no effect on the distribution of any of the mRNAs or proteins examined. Previously, Raff et al., showed that while MTs were required for perinuclear localization of cyclin B RNA, depolymerization of MTs did not affect posterior localization of cyclin B RNA in the embryo (Raff et al., 1990) . It was also reported that, in contrast to our results, actin was not required for posterior localization in the embryo. Since the data for this point were not shown and exact conditions used are not reported, it is dif®cult to compare our results to these previous studies.
Maintenance of anterior bicoid RNA does not require microtubules or actin ®laments
Since depolymerization of both actin ®laments and MTs appears to have no effect on the distribution of bicoid RNA in the early embryo, it is not clear how bicoid RNA is anchored anteriorly during embryomic development. In contrast to the oocyte where bicoid RNA is present in the cortex which is rich in cytoskeletal ®laments, in the early embryo bicoid RNA is located in the deeper cytoplasm. It has been reported that a small percentage of cytoplasmic RNAs are bound to intermediate ®laments in ®broblasts (Singer et al., 1989) ; therefore, it is possible that in the embryo bicoid RNA could be bound to this cytoskeletal network. De®nitive data that identi®es intermediate ®lament proteins in Drosophila is not yet available; thus, it is not clear if such a network exists.
Cooperation between different cytoskeletal components appear to mediate RNA localization
Based on the work of many investigators (reviewed in Pokrywka, 1995; Glotzer and Ephrussi, 1996) including our results (this study), we present a model for RNA localization of posterior pole plasm components (Fig. 6 ). During oogenesis, mRNAs are synthesized in the nurse cells and transported along microtubules which are oriented with their plus ends at the posterior of the oocyte during early stages (Fig. 6A) . Later, microtubules are important for cytoplasmic¯ow/streaming which may allow some mRNAs that are localized later in oogenesis to reach the posterior pole (e.g. nanos, cyclin B and gcl) (Fig. 6B) . At least for posteriorly localized mRNAs/proteins, it appears that microtubules are required only for these molecules to reach the posterior pole not for them to remain there (Clark et al., 1994; Pokrywka, 1995) . Once mRNAs are localized, the actin cytoskeleton is likely to be required to anchor mRNAs/proteins in late stage oocytes (based on the phenotypes of actin-binding protein mutants, Erde Âlyi et al., 1995; Manseau et al., 1996; Tetzlaff et al., 1996) and then maintain them at the posterior pole during early embryogenesis (this work, Fig. 6C ).
We suggest that during oogenesis actin ®laments are not absolutely required for posterior accumulation since transport of newly synthesized RNA along microtubules from the nurse cells to the posterior continues. This continued transport during mid-oogenesis may mask a requirement for anchoring via the actin cytoskeleton. This model would reconcile the somewhat contradictory data that CD depolymerization of actin has no effect on localization during late oogenesis, but tropomyosin and pro®lin mutants have reduced accumulation of posterior pole plasm components.
It is not known how the association of mRNAs with cytoskeletal elements is mediated. Two possible players are a myosin, 95F unconventional myosin, and a microtubule-binding protein, , that are concentrated at the posterior of the early Drosophila embryo (Lantz and Miller, 1998) . Posterior enrichment of both proteins in the early embryo is dependent on posterior pole plasm assembly (V. Lantz and K. Miller, unpublished data) . Their maintenence at the posterior depends on actin but not the microtubule cytoskeleton. These two cytoskeletal proteins, which are present in the same complex, may coordinate interaction between the actin and microtubule cytoskeletons and hence, play a role in anchoring of mRNAs and proteins targeted to the posterior pole. 
